B
BioAge Labs Inc.
BIOA · NASDAQ · Healthcare · 399M
Price · close
$9.48
-2.17% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.3×
Enterprise value / EBITDAEV/EBITDA
-2.0×
Free cash flow yieldFCF yield
-24.2%
Return on equityROE
-29.6%
Operating margin
-1031.5%
Net debt / EBITDAbalance-sheet strength
2.3×
Interest coverage
-133.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.